Michael Blumenkrantz is a Nephrology physician affiliated with Wadsworth Center. OpenAlex indexes 40 publications with 2,944 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2080 Century Park E
Suite 1207
Los Angeles, CA 900672015
Telephone
310-289-9824Registry record last updated 16 Jul 2013.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ardelyx, Inc.Program year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
44.5%Statin15.5%Rosuvastatin Calcium100%Part D≥45 patientsOther lipid modifying agents4.8%Vascepa67%Icosapent Ethyl33%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
26.9%GLP-1 receptor agonist5.7%Ozempic100%Part D<11 patientsProton pump inhibitor4.2%Omeprazole67%Pantoprazole Sodium33%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
5.3%l-Thyroxine5.3%Levothyroxine Sodium100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1985–1985 per NIH RePORTER. The latest:
- PROTEIN REQUIREMENTS IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
University of California Los Angeles
FY1985M01RR000865
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparisons of Hemodialysis and Peritoneal Dialysis: a Review of the Literature1
Contributions to nephrology
2015 - Absorption and Action of Insulin Added to Peritoneal Dialysate in Dogs
The Nephron journals/Nephron journals
2008
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”